Page 25 - Nasdaq Regn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the twenty-six research firms that are covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and nineteen have issued a buy […]

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given an average recommendation of “Moderate Buy” by the twenty-six brokerages that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and nineteen have issued a buy recommendation on the […]

E Fund Management Co. Ltd. lessened its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 4.7% in the second quarter, Holdings Channel.com reports. The firm owned 1,720 shares of the biopharmaceutical company’s stock after selling 85 shares during the period. E Fund Management Co. Ltd.’s holdings in Regeneron Pharmaceuticals were worth […]

Quadrant Capital Group LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 4.7% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 911 shares of the biopharmaceutical company’s stock after selling 45 shares during the period. Quadrant Capital […]

Summit X LLC lessened its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.8% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 861 shares of the biopharmaceutical company’s stock after selling 73 shares during the quarter. Summit X LLC’s holdings in […]